Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction

Molecules(2022)10.3390/molecules27113454Source: DataRank Database

Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction is a research paper published in Molecules (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.46)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Louis Gadina ORCID,Ewa Surmiak ORCID,Zefeng Wang ORCID,Bidong Zhang ORCID,Roberto Butera ORCID

Live enrichment

PubMed:35684392 PMC:PMC9181982 OpenAlex:https://openalex.org/W4281747243

National Science Centre

Grant: 2017/26/A/ST5/00572

National Science Centre

Grant: 675555

Accelerated Early staGe drug diScovery

National Science Centre

Grant: 2R01GM097082-05

Real-time discovery of inhibitors among billion compounds for preview and download

National Science Centre

Grant: 115489

European Lead Factory

National Science Centre

Grant: NPRP6-065-3-012

National Science Centre

Grant: 665250

National Science Centre

Grant: 754425

Personalised Medicine in Diabetic Chronic Disease Management

National Science Centre

Grant: 10504

National Science Centre

Grant: POWR.03.02.00-00-I013/16

COFUNDs ALERT

Grant: No 665250

Prominent

Grant: No 754425

NIGMS NIH HHS

Grant: R01 GM097082

European Lead Factory

Grant: No 115489

KWF Kankerbestrijding

Grant: No 10504

Accelerated Early stage drug dIScovery

Grant: No 675555

FWCI

0.46

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/27/11/3454/pdf?version=1653641439

publisherhttps://www.mdpi.com/1420-3049/27/11/3454/pdf?version=1653641439

publisherhttps://www.mdpi.com/1420-3049/27/11/3454/pdf

journalhttps://doi.org/10.3390/molecules27113454

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35684392

Fields of Study

Peptidase Inhibition and AnalysisMultiple Myeloma Research and TreatmentsCAR-T cell therapy research0301 basic medicine03 medical and health sciences

MeSH Terms

Biphenyl CompoundsHumansLigandsThalidomideB7-H1 AntigenProgrammed Cell Death 1 Receptor

Keywords

PomalidomideProgrammed cell deathChemistryBiphenylIC50Ligand (biochemistry)Cell cultureSmall moleculeIn vivoStereochemistryWestern blotMolecular biologyApoptosisBiochemistryIn vitroBiologyReceptorImmunologyBortezomibOrganic chemistrySmall-molecule InhibitorsImmune Checkpoint BlockadePd-1/pd-l1Programmed Cell Death 1 Receptor/antagonists & inhibitorsBiphenyl CompoundsProgrammed Cell Death 1 ReceptorB7-H1 Antigen/antagonists & inhibitorsLigandsArticleB7-H1 AntigenThalidomide/analogs & derivativesThalidomideQD241-441Humans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being